Cardiovascular Medicine
Showing 71-80 of 134 Results
-
Joshua Makower
Yock Family Professor and Professor of Bioengineering
Current Research and Scholarly InterestsDr. Josh Makower is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering and the Director of the Stanford Byers Center for Biodesign, the program he co-founded with Dr. Paul Yock twenty years ago. Josh helped create the fundamental structure of the Center’s core curriculum and is the chief architect of what is now called “The Biodesign Process.” Over the past 20 years since Josh and Paul founded Biodesign, this curriculum and the associated textbook has been used at Stanford and across the world to train hundreds of thousands of students, faculty and industry leaders on the Biodesign process towards the advancement of medical innovation for the improvement of patient care. Josh has practiced these same techniques directly as the Founder & Executive Chairman of ExploraMed, a medical device incubator, creating 9 companies since 1995. Transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard & TransVascular, acquired by Medtronic. Other ExploraMed/NEA ventures include Moximed, NC8 and Willow. Josh is also a Special Partner at NEA where he supports the healthcare team and medtech/healthtech investing practice. Josh serves on the boards of Allay Therapeutics, Revelle Aesthetics, Setpoint Medical, DOTS Technologies, Eargo, ExploraMed, Intrinsic Therapeutics, Moximed, Willow and Coravin. Josh holds over 300 patents and patent applications. He received an MBA from Columbia University, an MD from the NYU School of Medicine, a bachelor’s degree in Mechanical Engineering from MIT. Josh is a Member of the National Academy of Engineering and the College of Fellows of The American Institute for Medical and Biological Engineering and was awarded the Coulter Award for Healthcare Innovation by the Biomedical Engineering Society in 2018.
-
Neha Maheshwari Mantri
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Neha Mantri serves as the Director of the Structural Imaging Program and Director of the Women’s Cardiology Clinic at Palo Alto VA Health Care System (PAVA HCS). Given her expertise in advanced imaging, she serves as a reader in the Echocardiography Lab at Stanford Hospital. She also leads several echocardiography quality improvement projects, weekly multi-modality imaging educational seminars, and fellow workshops across the PAVA HCS and Stanford echo labs.
-
Michael V. McConnell, MD, MSEE
Current Research and Scholarly InterestsMy imaging research has involved clinical and molecular Imaging of cardiovascular disease, with a focus on coronary and vascular diseases, including atherosclerosis, aortic aneurysms, and vascular inflammation.
My prevention research has involved innovative technologies to reduce coronary and vascular disease, including early disease detection plus leveraging mobile health and AI to enhance heart heart in patients and populations. -
Mark Mercola
Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology
BioDr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative high throughput assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.
Prof. Mercola received an NIH MERIT award for his work on heart formation. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the National Institutes of Health (NIH), California Institute for Regenerative Medicine, Phospholamban Foundation and Fondation Leducq. -
Dr Tom Meredith, MD, PhD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr Tom Meredith, born and raised in Melbourne, Australia, is an academic interventional cardiologist and a clinical assistant professor at Stanford. He completed his medical and cardiology specialty training through the University of New South Wales and St Vincent's Hospital in Sydney, Australia. After obtaining Fellowship at the Royal Australian College of Physicians, he completed three years of coronary and structural interventional training across St Vincent’s Hospital and Stanford. Alongside his clinical training, he completed a master's degree in clinical trials research as well as a PhD through the Victor Chang Cardiac Research Institute, supported by competitive scholarship funding from the CSANZ and the Australian National Heart Foundation. During his PhD he developed and patented a novel algorithm to predict aortic stenosis severity from single-view echocardiography and his thesis was ultimately nominated for the Dean's Award. His research interests include cardiac remodelling in valvular heart disease and the application of supervised machine-learning methods to predict post-procedural outcomes. Outside medicine, Tom is a dedicated father and avid triathlete who has competed in multiple Ironman 70.3 World Championships.
-
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
-
Andrew Thai Nguyen
Clinical Scholar, Medicine - Cardiovascular Medicine
Postdoctoral Scholar, Cardiovascular MedicineBioDr. Andrew Nguyen is a Cardiologist and a Clinical Scholar in the Department of Medicine, Division of Cardiovascular Medicine. He earned his medical degree from Harvard Medical School in the Harvard-MIT Health Sciences and Technology Program. He then completed his residency in Internal Medicine at Stanford University, followed by fellowship training in Cardiovascular Medicine also at Stanford University.
As a non-invasive cardiologist, Dr. Nguyen cares for patients undergoing cancer therapy as well as cancer survivors in the Stanford Health Care Cardio-Oncology Program. He provides evidenced-based cardiovascular care for patients throughout their cancer journey while managing and preventing treatment toxicities. Dr. Nguyen is a physician scientist who is mentored by Dr. Paul Cheng and Dr. Tom Quertermous. His research blends his clinical interest in cardio-oncology with basic science to understand the complex interplay between cancer angiogenesis and ischemic heart disease. He is a recipient of the AHA Postdoctoral Fellowship Award, ACC/Merck Research Fellowship Award, and NIH F32 Award.
